COMMUNIQUÉS West-GlobeNewswire

INSYS Therapeutics Reaches Agreement in Principle to Settle Department of Justice Investigation
08/08/2018
Provisional Financial Settlement Terms Are Consistent with Previous Public Statements and Disclosures PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, [...]
AC Immune Reports Second Quarter 2018 Financial Results and Corporate Update
08/08/2018
New total cash position of approximately CHF 210 million that is expected to extend cash runway to Q3 2021, excluding potential incoming milestones Financial position strengthened after Q2 close due to issuance of new [...]
“Grindeks” concludes land purchase agreement for innovation centre development
08/08/2018
JSC “Grindeks” announces, it has expanded its territory and acquired a plot of land with buildings located in Riga, Krustpils street 63 for the development of innovation centre. The 92 584-square-meter plot of land in [...]
Frankfurt’s Clearstream Banking Lifts Settlement Restrictions on Securities Active in Medical Cannabis
08/08/2018
VANCOUVER, British Columbia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that Clearstream Banking, a major [...]
CORRECTION (UPDATED LINK): VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE
08/08/2018
Strong financial performance in H1 2018 Three medium-term strategic growth drivers fully on track Strategic in-licensing deal concluded with Cara Therapeutics Inc. Net sales and EBITDA guidance for 2018 raised and [...]
Shire plc: Rule 2.9 Announcement
08/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 8 August 2018 [...]
Motif Bio Announces Notice of Allowance for Two U.S. Iclaprim Patents with Expiration in 2037
08/08/2018
NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that [...]
GENEDRIVE PARTNERS WITH FIND TO EVALUATE A MOLECULAR DIAGNOSTIC KIT FOR HEPATITIS C VIRUS IN DECENTRALISED SETTINGS
08/08/2018
GENEDRIVE PARTNERS WITH FIND TO EVALUATE A MOLECULAR DIAGNOSTIC KIT FOR HEPATITIS C VIRUS IN DECENTRALISED SETTINGS Evaluation studies of the Genedrive® HCV ID Kit will take place in Cameroon and Georgia Assay designed [...]
Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018
08/08/2018
Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to DKK 54.3 billion. Sales of Victoza® increased by 2% to DKK 11.7 billion (12% in local currencies). Sales of Saxenda® increased by 35% to [...]
Advance Notice: Reviewed Financial Statement's announcement for the period 30 June 2018
08/08/2018
EASTPHARMA LTD. London, 08 August 2018 - EastPharma (EAST LI) informs that it will be releasing its reviewed financial statements for the period 30 June 2018 and a review of its main subsidiary DEVA Holding's financial [...]
Photocure ASA: Results for the second quarter of 2018
08/08/2018
Oslo, Norway, 8 August 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 56% in local currency for the U.S. market in the second quarter of 2018, contributing to Hexvix/Cysview revenues of NOK 42.4 [...]
Lundbeck realized 14% growth in revenue (local currencies) and 83% growth in EPS
08/08/2018
Valby, Aug. 08, 2018 (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 9,288 million in the first six months of 2018 representing an increase of 9% (14% in local currencies) compared to the same period in 2017 Revenue [...]
VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE
08/08/2018
Strong financial performance in H1 2018 Three medium-term strategic growth drivers fully on track Strategic in-licensing deal concluded with Cara Therapeutics Inc. Net sales and EBITDA guidance for 2018 raised and [...]
Bone Therapeutics SA Notice of Half Year 2018 Results
08/08/2018
Press release Bone Therapeutics Notice of Half Year 2018 Results Results to be announced on Thursday 30 August 2018 Gosselies, Belgium, 8 August 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), [...]
Bone Therapeutics SA publiera ses résultats semestriels, le 30 août 2018
08/08/2018
Communiqué de presse Bone Therapeutics publiera ses résultats semestriels, le 30 août 2018 Gosselies, Belgique, le 8 août 2018, 7h00 CEST - BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de thérapie [...]
ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update
08/08/2018
Phase 2b EDELWEISS clinical trial of linzagolix (OBE2109) in endometriosis related pelvic pain achieved primary and secondary endpoints Chief Commercial Officer hired as nolasiban moves closer to commercialization Net [...]
Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
08/08/2018
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today the pricing of an underwritten public offering of 9,090,909 primary shares of its common stock at a public [...]
Zogenix Prices Public Offering of Common Stock
08/08/2018
EMERYVILLE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, announced today [...]
FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmed’s ALIS for the Treatment of NTM Lung Disease Caused by MAC for Adult Patients with Limited or No Treatment Options
07/08/2018
--Advisory committee supports surrogate endpoint of sputum culture conversion-- --ALIS currently under FDA Priority Review; PDUFA action date set for September 28, 2018-- BRIDGEWATER, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE [...]

Pages